Compare $APUS vs $OSRH | Chartloom

Compare

$APUS vs $OSRH

Apimeds Pharmaceuticals US Inc · OSR Holdings Inc

APUS

Apimeds Pharmaceuticals US Inc

OSRH

OSR Holdings Inc

Compare $APUS vs $OSRH

Comparing Apimeds Pharmaceuticals US Inc and OSR Holdings Inc

APUSApimeds Pharmaceuticals US Inc

OSRHOSR Holdings Inc

APUSApimeds Pharmaceuticals US Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.8%

52W performance

-75.9%

FCF yield

-70.6%

OSRHOSR Holdings Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-4.6%

YTD performance

-64.4%

52W performance

-65.3%

FCF yield

-100.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APUS

OSRH

Detailed metrics comparison

APUS

Apimeds Pharmaceuticals US Inc

OSRH

OSR Holdings Inc

Market Cap

APUS$8M

OSRH$7M

Enterprise Value

APUS$22M

OSRH$11M

Price

APUS$5.02

OSRH$0.21

P/E Ratio

APUSN/A

OSRHN/A

P/S Ratio

APUS0.00x

OSRH4.08x

EV/Sales

APUS0.00x

OSRH6.25x

EV/EBITDA

APUS0.00x

OSRH0.00x

P/B Ratio

APUS0.05x

OSRH0.07x

P/FCF Ratio

APUSN/A

OSRHN/A

EV/FCF

APUS-4.06x

OSRH-1.53x

PEG Ratio

APUSN/A

OSRHN/A

Forward P/E (NTM)

APUSN/A

OSRHN/A

Forward P/S (NTM)

APUSN/A

OSRHN/A

Revenue (TTM)

APUS$0

OSRH$2M

Revenue Growth (YoY)

APUSN/A

OSRH-4.6%

Forward Rev Growth

APUS0.0%

OSRH0.0%

Gross Margin (TTM)

APUS0.0%

OSRH35.3%

Operating Margin (TTM)

APUS0.0%

OSRH0.0%

EBITDA Margin (TTM)

APUS0.0%

OSRH-410.1%

Net Margin (TTM)

APUS0.0%

OSRH-593.2%

FCF Margin (TTM)

APUSN/A

OSRH-407.9%

Net Income (TTM)

APUS$-58M

OSRH$-11M

FCF (TTM)

APUS$-5M

OSRH$-7M

EPS (TTM)

APUS-$33.95

OSRH-$0.25

ROE (TTM)

APUS-5898.0%

OSRH-1167.0%

ROA (TTM)

APUS-5261.0%

OSRH-624.0%

ROIC (TTM)

APUS-5458.0%

OSRH-1110.0%

Cash

APUS$278K

OSRH$1M

Debt

APUS$14M

OSRH$5M

Net Cash/Debt

APUS$-14M

OSRH$-4M

Current Ratio (TTM)

APUS0.51x

OSRH0.18x

Quick Ratio (TTM)

APUS0.40x

OSRH0.14x

Debt/Equity (TTM)

APUS0.14x

OSRH0.05x

Debt/Assets (TTM)

APUS0.0%

OSRH0.0%

Interest Coverage (TTM)

APUSN/A

OSRHN/A

Net Debt/EBITDA (TTM)

APUS0.00x

OSRH0.00x

Beta

APUS2.60

OSRH0.51

52W Performance

APUS-75.9%

OSRH-65.3%

YTD Performance

APUS-69.8%

OSRH-64.4%

% from 52W High

APUS-91.6%

OSRH-76.9%

% from 52W Low

APUS232.5%

OSRH180.0%

Asset Turnover (TTM)

APUS0.00x

OSRH0.01x

FCF Yield (TTM)

APUS-70.6%

OSRH-100.0%

Earnings Yield (TTM)

APUS-767.4%

OSRH-145.5%

Dividend Yield (TTM)

APUSN/A

OSRHN/A

Rule of 40

APUS0.0

OSRH-412.5

EV/GP/RG

APUSN/A

OSRHN/A

Ticker research

View APUS research View OSRH research

Metric	APUS Apimeds Pharmaceuticals US Inc	OSRH OSR Holdings Inc
Market & Valuation
Market Cap	$8M	$7M
Enterprise Value	$22M	$11M
Price	$5.02	$0.21
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	4.08x
EV/Sales	0.00x	6.25x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.05x	0.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.06x	-1.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-4.6%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	35.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-410.1%
Net Margin (TTM)	0.0%	-593.2%
FCF Margin (TTM)	N/A	-407.9%
Net Income (TTM)	$-58M	$-11M
FCF (TTM)	$-5M	$-7M
EPS (TTM)	-$33.95	-$0.25
ROE (TTM)	-5898.0%	-1167.0%
ROA (TTM)	-5261.0%	-624.0%
ROIC (TTM)	-5458.0%	-1110.0%
Financial Health
Cash	$278K	$1M
Debt	$14M	$5M
Net Cash/Debt	$-14M	$-4M
Current Ratio (TTM)	0.51x	0.18x
Quick Ratio (TTM)	0.40x	0.14x
Debt/Equity (TTM)	0.14x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	0.51
52W Performance	-75.9%	-65.3%
YTD Performance	-69.8%	-64.4%
% from 52W High	-91.6%	-76.9%
% from 52W Low	232.5%	180.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-70.6%	-100.0%
Earnings Yield (TTM)	-767.4%	-145.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-412.5
EV/GP/RG	N/A	N/A
Ticker research	View APUS research	View OSRH research

Valuation

P/S Ratio

APUS

0.00x

OSRH

4.08x

EV/FCF

APUS

-4.06x

OSRH

-1.53x

Growth & revenue

Revenue Growth TTM

OSRH

-4.6%

Forward Revenue Growth

APUS

0.0%

OSRH

0.0%

Profitability & performance

Gross Margin

OSRH

35.3%

APUS

0.0%

ROE

OSRH

-1167.0%

APUS

-5898.0%

FCF Yield %

APUS

-70.6%

OSRH

-100.0%

52-Week Performance

OSRH

-65.3%

APUS

-75.9%

Detailed metrics comparison

APUS

Apimeds Pharmaceuticals US Inc

OSRH

OSR Holdings Inc

Market Cap

APUS$8M

OSRH$7M

Enterprise Value

APUS$22M

OSRH$11M

Price

APUS$5.02

OSRH$0.21

P/E Ratio

APUSN/A

OSRHN/A

P/S Ratio

APUS0.00x

OSRH4.08x

EV/Sales

APUS0.00x

OSRH6.25x

EV/EBITDA

APUS0.00x

OSRH0.00x

P/B Ratio

APUS0.05x

OSRH0.07x

P/FCF Ratio

APUSN/A

OSRHN/A

EV/FCF

APUS-4.06x

OSRH-1.53x

PEG Ratio

APUSN/A

OSRHN/A

Forward P/E (NTM)

APUSN/A

OSRHN/A

Forward P/S (NTM)

APUSN/A

OSRHN/A

Revenue (TTM)

APUS$0

OSRH$2M

Revenue Growth (YoY)

APUSN/A

OSRH-4.6%

Forward Rev Growth

APUS0.0%

OSRH0.0%

Gross Margin (TTM)

APUS0.0%

OSRH35.3%

Operating Margin (TTM)

APUS0.0%

OSRH0.0%

EBITDA Margin (TTM)

APUS0.0%

OSRH-410.1%

Net Margin (TTM)

APUS0.0%

OSRH-593.2%

FCF Margin (TTM)

APUSN/A

OSRH-407.9%

Net Income (TTM)

APUS$-58M

OSRH$-11M

FCF (TTM)

APUS$-5M

OSRH$-7M

EPS (TTM)

APUS-$33.95

OSRH-$0.25

ROE (TTM)

APUS-5898.0%

OSRH-1167.0%

ROA (TTM)

APUS-5261.0%

OSRH-624.0%

ROIC (TTM)

APUS-5458.0%

OSRH-1110.0%

Cash

APUS$278K

OSRH$1M

Debt

APUS$14M

OSRH$5M

Net Cash/Debt

APUS$-14M

OSRH$-4M

Current Ratio (TTM)

APUS0.51x

OSRH0.18x

Quick Ratio (TTM)

APUS0.40x

OSRH0.14x

Debt/Equity (TTM)

APUS0.14x

OSRH0.05x

Debt/Assets (TTM)

APUS0.0%

OSRH0.0%

Interest Coverage (TTM)

APUSN/A

OSRHN/A

Net Debt/EBITDA (TTM)

APUS0.00x

OSRH0.00x

Beta

APUS2.60

OSRH0.51

52W Performance

APUS-75.9%

OSRH-65.3%

YTD Performance

APUS-69.8%

OSRH-64.4%

% from 52W High

APUS-91.6%

OSRH-76.9%

% from 52W Low

APUS232.5%

OSRH180.0%

Asset Turnover (TTM)

APUS0.00x

OSRH0.01x

FCF Yield (TTM)

APUS-70.6%

OSRH-100.0%

Earnings Yield (TTM)

APUS-767.4%

OSRH-145.5%

Dividend Yield (TTM)

APUSN/A

OSRHN/A

Rule of 40

APUS0.0

OSRH-412.5

EV/GP/RG

APUSN/A

OSRHN/A

Ticker research

View APUS research View OSRH research

Metric	APUS Apimeds Pharmaceuticals US Inc	OSRH OSR Holdings Inc
Market & Valuation
Market Cap	$8M	$7M
Enterprise Value	$22M	$11M
Price	$5.02	$0.21
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	4.08x
EV/Sales	0.00x	6.25x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.05x	0.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.06x	-1.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-4.6%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	35.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-410.1%
Net Margin (TTM)	0.0%	-593.2%
FCF Margin (TTM)	N/A	-407.9%
Net Income (TTM)	$-58M	$-11M
FCF (TTM)	$-5M	$-7M
EPS (TTM)	-$33.95	-$0.25
ROE (TTM)	-5898.0%	-1167.0%
ROA (TTM)	-5261.0%	-624.0%
ROIC (TTM)	-5458.0%	-1110.0%
Financial Health
Cash	$278K	$1M
Debt	$14M	$5M
Net Cash/Debt	$-14M	$-4M
Current Ratio (TTM)	0.51x	0.18x
Quick Ratio (TTM)	0.40x	0.14x
Debt/Equity (TTM)	0.14x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	0.51
52W Performance	-75.9%	-65.3%
YTD Performance	-69.8%	-64.4%
% from 52W High	-91.6%	-76.9%
% from 52W Low	232.5%	180.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-70.6%	-100.0%
Earnings Yield (TTM)	-767.4%	-145.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-412.5
EV/GP/RG	N/A	N/A
Ticker research	View APUS research	View OSRH research